Cindy Tahl
General Counsel, Fate Therapeutics.
Companies
- Fate TherapeuticsOfficer Apr 2, 2021 to now1
- Fate TherapeuticsGeneral counsel Oct 16, 2015 to Jul 31, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Fate Therapeutics FATE589,355 shares3$1.1M at $1.79Aug 4, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 4, 2026Sold 38,800 shares at $2.46 of Fate Therapeutics3
- May 20, 2026Sold 25,590 shares at $1.88 of Fate Therapeutics4
- May 6, 2026Exercised options 44,444 shares at $1.05 of Fate Therapeutics5
- May 6, 2026Exercised options 122,220 shares at $1.32 of Fate Therapeutics5
- Jan 15, 2026Granted 100,000 shares of Fate Therapeutics6
- Jan 9, 2026Sold 10,589 shares at $1.06 of Fate Therapeutics7
- Aug 4, 2025Sold 9,037 shares at $1.06 of Fate Therapeutics8
- Jan 15, 2025Granted 70,000 shares of Fate Therapeutics9
- Jan 10, 2025Sold 5,654 shares at $1.55 of Fate Therapeutics10
- Jul 29, 2024Granted 200,000 shares of Fate Therapeutics11
- Jan 9, 2024Sold 10,874 shares at $4.37 of Fate Therapeutics12
- Nov 9, 2023Sold 24,363 shares at $2.40 of Fate Therapeutics13
- Jan 10, 2023Sold 11,553 shares at $5.24 of Fate Therapeutics14
- Jun 1, 2022Sold 25,000 shares at $22.96 of Fate Therapeutics15
- Jun 1, 2022Exercised options 25,000 shares at $6.55 of Fate Therapeutics15
- Apr 1, 2022Sold 25,000 shares at $38.85 of Fate Therapeutics16
- Apr 1, 2022Exercised options 5,567 shares at $6.55 of Fate Therapeutics16
- Apr 1, 2022Exercised options 19,433 shares at $4.84 of Fate Therapeutics16
- Jan 25, 2022Granted 33,302 shares of Fate Therapeutics17
- Jan 11, 2022Sold 536 shares at $49.15 of Fate Therapeutics18
- Jan 11, 2022Sold 4,883 shares at $48.46 of Fate Therapeutics18
- Jan 10, 2022Sold 643 shares at $47.15 of Fate Therapeutics19
- Jan 10, 2022Sold 7,095 shares at $46.37 of Fate Therapeutics19
- Jan 3, 2022Sold 861 shares at $60.31 of Fate Therapeutics20
- Jan 3, 2022Sold 27,812 shares at $59.86 of Fate Therapeutics20
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARFate Therapeutics, Officer
- 2SEC EDGARFate Therapeutics, General counsel
- 3
- 4SEC EDGARForm 4 filed May 21, 2026
- 5SEC EDGARForm 4 filed May 7, 2026
- 6SEC EDGARForm 4 filed Jan 16, 2026
- 7SEC EDGARForm 4 filed Jan 12, 2026
- 8SEC EDGARForm 4 filed Aug 5, 2025
- 9SEC EDGARForm 4 filed Jan 16, 2025
- 10SEC EDGARForm 4 filed Jan 13, 2025
- 11SEC EDGARForm 4 filed Jul 31, 2024
- 12SEC EDGARForm 4 filed Jan 10, 2024
- 13SEC EDGARForm 4 filed Nov 13, 2023
- 14SEC EDGARForm 4 filed Jan 11, 2023
- 15SEC EDGARForm 4 filed Jun 2, 2022
- 16SEC EDGARForm 4 filed Apr 4, 2022
- 17SEC EDGARForm 4 filed Jan 27, 2022
- 18SEC EDGARForm 4 filed Jan 13, 2022
- 19SEC EDGARForm 4 filed Jan 12, 2022
- 20SEC EDGARForm 4 filed Jan 4, 2022